Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114703

Protective action of luminal bile salts in necrotizing acute pancreatitis in mice.

G Gomez, C M Townsend Jr, D W Green, S Rajaraman, T Uchida, G H Greeley Jr, R D Soloway, and J C Thompson

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Gomez, G. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Townsend, C. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Green, D. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Rajaraman, S. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Uchida, T. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Greeley, G. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Soloway, R. in: PubMed | Google Scholar

Department of Surgery, University of Texas Medical Branch, Galveston 77550.

Find articles by Thompson, J. in: PubMed | Google Scholar

Published July 1, 1990 - More info

Published in Volume 86, Issue 1 on July 1, 1990
J Clin Invest. 1990;86(1):323–331. https://doi.org/10.1172/JCI114703.
© 1990 The American Society for Clinical Investigation
Published July 1, 1990 - Version history
View PDF
Abstract

Bile salts in the intestinal lumen act to inhibit the release of cholecystokinin (CCK). Recent studies have shown that CCK may play a permissive role in the development of acute pancreatitis. In this study, the amount of luminal bile salts in female Swiss Webster mice was either decreased by feeding 4% (wt/wt) cholestyramine or increased by feeding 0.5% sodium taurocholate for 1 wk. Plasma levels of CCK were stimulated by cholestyramine and inhibited by taurocholate. Then, acute pancreatitis was induced either by caerulein injections, or by feeding a choline-deficient, ethionine-supplemented (CDE) diet. Feeding of cholestyramine significantly decreased survival from 25% to 0% in the CDE pancreatitis, and increased the magnitude of elevation of serum amylase levels and the extent of pancreatic necrosis in both models of pancreatitis; CCK-receptor blockade with CR-1409 completely abolished the adverse effects of cholestyramine. In contrast, feeding of taurocholate significantly increased survival to 100% and decreased the elevation of serum amylase and pancreatic necrosis; CCK-8 antagonized these actions of taurocholate. Luminal bile salts appear to provide a physiologic protection against necrotizing pancreatitis, at least in part, both by inhibiting the release of CCK and by promoting resistance of the pancreas to CCK excessive stimulation in vivo.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 323
page 323
icon of scanned page 324
page 324
icon of scanned page 325
page 325
icon of scanned page 326
page 326
icon of scanned page 327
page 327
icon of scanned page 328
page 328
icon of scanned page 329
page 329
icon of scanned page 330
page 330
icon of scanned page 331
page 331
Version history
  • Version 1 (July 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts